First Author Name,Title,Study_nr2,Study_nr,disease_status,PMID,Language,Country studied,number_of_patients,condition,labs,lower_range,upper_range,Median,Q1,Q3,IQR,Mean,SD,ne,mean_ne,se_ne,nc,mean_nc,se_nc
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,albumin,,,,,,,,,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,albumin,,,,,,,,,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,ALT,,,23,15,36,21,23,15.55555556,36,35,28.1481481,102,23,15.55555556
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,ALT,,,35,19,57,38,35,28.14814815,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,AST,,,29,21,38,17,29,12.59259259,36,52,29.62962963,102,29,12.59259259
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,AST,,,52,30,70,40,52,29.62962963,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,creatinine,,,71,58,84,26,71,19.25925926,36,80,29.62962963,102,71,19.25925926
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,creatinine,,,80,66,106,40,80,29.62962963,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,CRP,,,,,,,,,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,CRP,,,,,,,,,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,D-dimer,,,0.166,0.101,0.285,0.184,0.166,0.136296296,36,0.414,0.839259259,102,0.166,0.136296296
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,D-dimer,,,0.414,0.191,1.324,1.133,0.414,0.839259259,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,hemoglobin,,,,,,,,,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,hemoglobin,,,,,,,,,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,LDH,,,212,171,291,120,212,88.88888889,36,435,217.7777778,102,212,88.88888889
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,LDH,,,435,302,596,294,435,217.7777778,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,leucocytes,,,4.3,3.3,5.4,2.1,4.3,1.555555556,36,6.6,4.592592593,102,4.3,1.555555556
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,leucocytes,,,6.6,3.6,9.8,6.2,6.6,4.592592593,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,lymphocytes,,,0.9,0.6,1.2,0.6,0.9,0.444444444,36,0.8,0.296296296,102,0.9,0.444444444
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,lymphocytes,,,0.8,0.5,0.9,0.4,0.8,0.296296296,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,monocytes,,,0.4,0.3,0.5,0.2,0.4,0.148148148,36,0.4,0.148148148,102,0.4,0.148148148
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,monocytes,,,0.4,0.3,0.5,0.2,0.4,0.148148148,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,neutrophiles,,,2.7,1.9,3.9,2,2.7,1.481481481,36,4.6,3.925925926,102,2.7,1.481481481
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,neutrophiles,,,4.6,2.6,7.9,5.3,4.6,3.925925926,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,potassium,,,,,,,,,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,potassium,,,,,,,,,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,Procalcitonin,,,,,,,,,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,Procalcitonin,,,,,,,,,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,sodium,,,,,,,,,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,sodium,,,,,,,,,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,thrombocytes,,,165,125,188,63,165,46.66666667,36,142,61.48148148,102,165,46.66666667
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,thrombocytes,,,142,119,202,83,142,61.48148148,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),non-severe,32031570,English,China,36,,Time_onset_admission,,,6,3,7,4,6,2.962962963,36,,,102,,
"Wang et al, 2020","Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",S86,a3 (n=36),severe,32031570,English,China,36,,Time_onset_admission,,,8,4.5,10,5.5,8,4.074074074,36,,,102,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,albumin,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,albumin,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,ALT,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,ALT,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,AST,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,AST,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,creatinine,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,creatinine,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,CRP,,,28.7,9.5,52.1,42.6,28.7,31.55555556,58,47.6,49.25925926,82,28.7,31.55555556
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,CRP,,,47.6,20.6,87.1,66.5,47.6,49.25925926,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,D-dimer,,,0.2,0.1,0.3,0.2,0.2,0.148148148,58,0.4,1.62962963,82,0.2,0.148148148
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,D-dimer,,,0.4,0.2,2.4,2.2,0.4,1.62962963,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,hemoglobin,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,hemoglobin,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,LDH,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,LDH,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,leucocytes,,,4.5,3.5,5.9,2.4,4.5,1.777777778,58,5.3,3.703703704,82,4.5,1.777777778
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,leucocytes,,,5.3,4,9,5,5.3,3.703703704,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,lymphocytes,,,0.8,0.6,1.2,0.6,0.8,0.444444444,58,0.7,0.37037037,82,0.8,0.444444444
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,lymphocytes,,,0.7,0.5,1,0.5,0.7,0.37037037,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,monocytes,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,monocytes,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,neutrophiles,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,neutrophiles,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,potassium,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,potassium,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,Procalcitonin,,,0.05,0.03,0.1,0.07,0.05,0.051851852,58,0.1,0.177777778,82,0.05,0.051851852
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,Procalcitonin,,,0.1,0.06,0.3,0.24,0.1,0.177777778,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,sodium,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,sodium,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,thrombocytes,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,thrombocytes,,,,,,,,,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),non-severe,32077115,English,China,58,,Time_onset_admission,,,8,5,11,6,8,4.444444444,58,,,82,,
"Zhang et al, 2020","Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China",S110,a11 (n=58),severe,32077115,English,China,58,,Time_onset_admission,,,7,6,12,6,7,4.444444444,58,,,82,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,a10,a10 (n=13),non-severe,32109443,English,China,13,,albumin,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,albumin,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,ALT,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,ALT,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,AST,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,AST,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,creatinine,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,creatinine,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,CRP,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,CRP,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,D-dimer,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,D-dimer,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,hemoglobin,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,hemoglobin,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,LDH,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,LDH,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,leucocytes,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,leucocytes,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,lymphocytes,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,lymphocytes,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,monocytes,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,monocytes,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,neutrophiles,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,neutrophiles,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,potassium,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,potassium,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,Procalcitonin,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,Procalcitonin,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,sodium,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,sodium,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,thrombocytes,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,thrombocytes,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),non-severe,32109443,English,China,13,,Time_onset_admission,,,,,,,,,13,,,37,,
"Xu et al, 2020",Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2,S94,a10 (n=13),severe,32109443,English,China,13,,Time_onset_admission,,,,,,,,,13,,,37,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,albumin,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,albumin,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,ALT,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,ALT,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,AST,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,AST,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,creatinine,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,creatinine,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,CRP,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,CRP,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,D-dimer,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,D-dimer,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,hemoglobin,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,hemoglobin,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,LDH,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,LDH,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,leucocytes,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,leucocytes,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,lymphocytes,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,lymphocytes,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,monocytes,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,monocytes,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,neutrophiles,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,neutrophiles,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,potassium,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,potassium,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,Procalcitonin,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,Procalcitonin,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,sodium,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,sodium,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,thrombocytes,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,thrombocytes,,,,,,,,,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),non-severe,32112886,English,China,46,,Time_onset_admission,,, ,,,,4.5,3.5,46,,,216,,
"Tian et al, 2020",Characteristics of COVID-19 infection in Beijing,S80,a2 (n=46),severe,32112886,English,China,46,,Time_onset_admission,,, ,,,,5.2,4.6,46,,,216,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,albumin,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,albumin,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,ALT,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,ALT,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,AST,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,AST,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,creatinine,,,66,53,80,27,66,20,24,82.5,38.51851852,126,66,20
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,creatinine,,,82.5,67,119,52,82.5,38.51851852,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,CRP,,,30.9,7.1,66.9,59.8,30.9,44.2962963,24,84.9,67.7037037,126,30.9,44.2962963
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,CRP,,,84.9,56.8,148.2,91.4,84.9,67.7037037,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,D-dimer,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,D-dimer,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,hemoglobin,,,,,,,129.5,15.5,24,122.5,23,126,129.5,15.5
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,hemoglobin,,, ,,,,122.5,23,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,LDH,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,LDH,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,leucocytes,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,leucocytes,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,lymphocytes,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,lymphocytes,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,monocytes,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,monocytes,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,neutrophiles,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,neutrophiles,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,potassium,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,potassium,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,Procalcitonin,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,Procalcitonin,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,sodium,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,sodium,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,thrombocytes,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,thrombocytes,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),non-severe,32141280,China,English,24,,Time_onset_admission,,,,,,,,,24,,,126,,
"Chen et al, 2020",Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19,S9,a9 (n=24),severe,32141280,China,English,24,,Time_onset_admission,,,,,,,,,24,,,126,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,albumin,,, , , ,,,,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,albumin,,,,,,,,,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,ALT,,,24,16,40,24,24,17.77777778,14,31.5,21.4814815,55,24,17.77777778
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,ALT,,,31.5,23,52,29,31.5,21.48148148,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,AST,,,26,21,39,18,26,13.33333333,14,40.5,28.14814815,55,26,13.33333333
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,AST,,,40.5,24,62,38,40.5,28.14814815,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,creatinine,,,65.3,58,78.5,20.5,65.3,15.18518519,14,71.5,20.66666667,55,65.3,15.18518519
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,creatinine,,,71.5,52.5,80.4,27.9,71.5,20.66666667,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,CRP,,,11.3,6.53,26.3,19.77,11.3,14.64444444,14,81.55,42.25925926,55,11.3,14.64444444
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,CRP,,,81.55,48.85,105.9,57.05,81.55,42.25925926,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,D-dimer,,, , , ,,,,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,D-dimer,,,,,,,,,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,hemoglobin,,,134,124,147,23,134,17.03703704,14,128,14.07407407,55,134,17.03703704
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,hemoglobin,,,128,117,136,19,128,14.07407407,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,LDH,,,207,181,274,93,207,68.88888889,14,517.5,208.8888889,55,207,68.88888889
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,LDH,,,517.5,267,549,282,517.5,208.8888889,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,leucocytes,,,3.57,2.96,4.93,1.97,3.57,1.459259259,14,6.52,2.540740741,55,3.57,1.459259259
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,leucocytes,,,6.52,4.3,7.73,3.43,6.52,2.540740741,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,lymphocytes,,,1.19,0.95,1.46,0.51,1.19,0.377777778,14,0.61,0.466666667,55,1.19,0.377777778
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,lymphocytes,,,0.61,0.37,1,0.63,0.61,0.466666667,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,monocytes,,,0.31,0.24,0.46,0.22,0.31,0.162962963,14,0.27,0.2,55,0.31,0.162962963
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,monocytes,,,0.27,0.14,0.41,0.27,0.27,0.2,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,neutrophiles,,,2.16,1.6,2.7,1.1,2.16,0.814814815,14,5.24,2.622222222,55,2.16,0.814814815
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,neutrophiles,,,5.24,2.9,6.44,3.54,5.24,2.622222222,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,potassium,,, , , ,,,,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,potassium,,,,,,,,,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,Procalcitonin,,,0.13,0.13,0.15,0.02,0.13,0.014814815,14,0.13,0.014814815,55,0.13,0.014814815
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,Procalcitonin,,,0.13,0.13,0.15,0.02,0.13,0.014814815,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,sodium,,, , , ,,,,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,sodium,,,,,,,,,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,thrombocytes,,,172,138,206,68,172,50.37037037,14,167,52.59259259,55,172,50.37037037
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,thrombocytes,,,167,144,215,71,167,52.59259259,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),non-severe,32176772,China,English,14,,Time_onset_admission,,,6,4,9,5,6,3.703703704,14,,,55,,
"Wang et al, 2020","Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China",S87,a6 (n=14),severe,32176772,China,English,14,,Time_onset_admission,,,7,4,9,5,7,3.703703704,14,,,55,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,albumin,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,albumin,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,ALT,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,ALT,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,AST,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,AST,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,creatinine,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,creatinine,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,CRP,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,CRP,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,D-dimer,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,D-dimer,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,hemoglobin,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,hemoglobin,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,LDH,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,LDH,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,leucocytes,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,leucocytes,,, ,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,lymphocytes,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,lymphocytes,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,monocytes,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,monocytes,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,neutrophiles,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,neutrophiles,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,potassium,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,potassium,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,Procalcitonin,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,Procalcitonin,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,sodium,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,sodium,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,thrombocytes,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,thrombocytes,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),non-severe,32179910,China,English,2,,Time_onset_admission,,,,,,,,,2,,,14,,
"Wang et al, 2020","Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China",S88,a4 (n=2),severe,32179910,China,English,2,,Time_onset_admission,,,,,,,,,2,,,14,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,albumin,,,40.2,38,42.4,4.4,40.2,3.259259259,9,38.55,2.162962963,82,40.2,3.259259259
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,albumin,,,38.55,36.33,39.25,2.92,38.55,2.162962963,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,ALT,,,18,13,29,16,18,11.85185185,9,19.9,8.88888889,82,18,11.85185185
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,ALT,,,19.9,14,26,12,19.9,8.888888889,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,AST,,,21,17,29,12,21,8.888888889,9,27,2.407407407,82,21,8.888888889
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,AST,,,27,23.75,27,3.25,27,2.407407407,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,creatinine,,,66,57,76,19,66,14.07407407,9,81.5,14.62962963,82,66,14.07407407
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,creatinine,,,81.5,70.75,90.5,19.75,81.5,14.62962963,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,CRP,,,5.98,1.4,11.3,9.9,5.98,7.333333333,9,30.63,67.33333333,82,5.98,7.333333333
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,CRP,,,30.63,12.5,103.4,90.9,30.63,67.33333333,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,D-dimer,,,0.3,0.106,0.4,0.294,0.3,0.217777778,9,0.45,0.240740741,82,0.3,0.217777778
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,D-dimer,,,0.45,0.16,0.485,0.325,0.45,0.240740741,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,hemoglobin,,,135,126,147,21,135,15.55555556,9,130,17.77777778,82,135,15.55555556
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,hemoglobin,,,130,118,142,24,130,17.77777778,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,LDH,,,,,,,,,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,LDH,,, , , ,,,,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,leucocytes,,,4.97,4.02,5.65,1.63,4.97,1.207407407,9,5.23,1.525925926,82,4.97,1.207407407
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,leucocytes,,,5.23,4.74,6.8,2.06,5.23,1.525925926,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,lymphocytes,,,1.4,1.05,1.75,0.7,1.4,0.518518519,9,0.9,0.444444444,82,1.4,0.518518519
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,lymphocytes,,,0.9,0.7,1.3,0.6,0.9,0.444444444,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,monocytes,,,0.4,0.3,0.59,0.29,0.4,0.214814815,9,0.35,0.296296296,82,0.4,0.214814815
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,monocytes,,,0.35,0.3,0.7,0.4,0.35,0.296296296,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,neutrophiles,,,2.8,2.18,3.49,1.31,2.8,0.97037037,9,3.32,2.088888889,82,2.8,0.97037037
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,neutrophiles,,,3.32,3,5.82,2.82,3.32,2.088888889,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,potassium,,,4.09,3.72,4.27,0.55,4.09,0.407407407,9,3.82,0.096296296,82,4.09,0.407407407
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,potassium,,,3.82,3.76,3.89,0.13,3.82,0.096296296,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,Procalcitonin,,,0.03,0,0.04,0.04,0.03,0.02962963,9,,,82,0.03,0.02962963
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,Procalcitonin,,,,,,,,,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,sodium,,,139.6,137.6,142,4.4,139.6,3.259259259,9,137.85,3.022222222,82,139.6,3.259259259
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,sodium,,,137.85,135.3,139.38,4.08,137.85,3.022222222,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,thrombocytes,,,198,144,248,104,198,77.03703704,9,152,60,82,198,77.03703704
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,thrombocytes,,,152,127,208,81,152,60,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),non-severe,32181807,China,English,9,,Time_onset_admission,,,,,,,,,9,,,82,,
"Qian et al, 2020","Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series.",S65,a7 (n=9),severe,32181807,China,English,9,,Time_onset_admission,,,,,,,,,9,,,82,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,albumin,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,albumin,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,ALT,,,,,, ,33.6,24.5,3,36,19.52,27,33.6,24.5
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,ALT,,,,,, ,36,19.52,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,AST,,,,,,,43.56,21.03,3,45.33,12.9,27,43.56,21.03
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,AST,,,,,,,45.33,12.9,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,creatinine,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,creatinine,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,CRP,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,CRP,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,D-dimer,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,D-dimer,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,hemoglobin,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,hemoglobin,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,LDH,,,,,,,528.15,188.64,3,772.33,292.13,27,528.15,188.64
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,LDH,,,,,,,772.33,292.13,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,leucocytes,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,leucocytes,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,lymphocytes,,, ,,,,1.01,0.45,3,1.6,0.55,27,1.01,0.45
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,lymphocytes,,, ,,,,1.6,0.55,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,monocytes,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,monocytes,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,neutrophiles,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,neutrophiles,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,potassium,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,potassium,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,Procalcitonin,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,Procalcitonin,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,sodium,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,sodium,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,thrombocytes,,,,,,,192.26,58.12,3,169.7,48.95,27,192.26,58.12
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,thrombocytes,,,,,,,169.7,48.95,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),non-severe,32181903,China,English,3,,Time_onset_admission,,,,,,,,,3,,,27,,
"Qu et al, 2020",Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19,S65,a8 (n=3),severe,32181903,China,English,3,,Time_onset_admission,,,,,,,,,3,,,27,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,albumin,,,49.9,37.4,43.6,6.2,49.9,4.592592593,40,36,4.074074074,95,49.9,4.592592593
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,albumin,,,36,33,38.5,5.5,36,4.074074074,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,ALT,,,21.7,14.8,36.9,22.1,21.7,16.37037037,40,26.6,13.9259259,95,21.7,16.37037037
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,ALT,,,26.6,14.5,33.3,18.8,26.6,13.92592593,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,AST,,,22.4,16.9,30.5,13.6,22.4,10.07407407,40,33.6,13.7037037,95,22.4,10.07407407
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,AST,,,33.6,25.7,44.2,18.5,33.6,13.7037037,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,creatinine,,,66,55,79,24,66,17.77777778,40,63.5,16.88888889,95,66,17.77777778
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,creatinine,,,63.5,51.5,74.3,22.8,63.5,16.88888889,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,CRP,,,7.7,1.9,31.1,29.2,7.7,21.62962963,40,91,61.92592593,95,7.7,21.62962963
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,CRP,,,91,52.7,136.3,83.6,91,61.92592593,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,D-dimer,,,0.3,0.2,0.5,0.3,0.3,0.222222222,40,0.6,0.518518519,95,0.3,0.222222222
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,D-dimer,,,0.6,0.4,1.1,0.7,0.6,0.518518519,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,hemoglobin,,,134,124,147,23,134,17.03703704,40,130,17.03703704,95,134,17.03703704
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,hemoglobin,,,130,120,143,23,130,17.03703704,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,LDH,,,212,179.5,259,79.5,212,58.88888889,40,309,114.4444444,95,212,58.88888889
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,LDH,,,309,253.8,408.3,154.5,309,114.4444444,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,leucocytes,,,5.5,4,8,4,5.5,2.962962963,40,5.2,1.481481481,95,5.5,2.962962963
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,leucocytes,,,5.2,4.9,6.9,2,5.2,1.481481481,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,lymphocytes,,,1.2,0.8,1.6,0.8,1.2,0.592592593,40,0.8,0.296296296,95,1.2,0.592592593
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,lymphocytes,,,0.8,0.6,1,0.4,0.8,0.296296296,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,monocytes,,,,,,,,,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,monocytes,,,,,,,,,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,neutrophiles,,,3.6,3,3.9,0.9,3.6,0.666666667,40,4.1,1.925925926,95,3.6,0.666666667
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,neutrophiles,,,4.1,3.1,5.7,2.6,4.1,1.925925926,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,potassium,,,4,3.7,4.5,0.8,4,0.592592593,40,3.8,0.592592593,95,4,0.592592593
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,potassium,,,3.8,3.5,4.3,0.8,3.8,0.592592593,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,Procalcitonin,,,0.04,0.03,0.06,0.03,0.04,0.022222222,40,0.11,0.059259259,95,0.04,0.022222222
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,Procalcitonin,,,0.11,0.08,0.16,0.08,0.11,0.059259259,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,sodium,,,139,137.2,141,3.8,139,2.814814815,40,136.5,3.703703704,95,139,2.814814815
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,sodium,,,136.5,133,138,5,136.5,3.703703704,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,thrombocytes,,,170,136,234,98,170,72.59259259,40,127,70.37037037,95,170,72.59259259
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,thrombocytes,,,127,118,213,95,127,70.37037037,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),non-severe,32198776,China,English,40,,Time_onset_admission,,,,,,,,,40,,,95,,
"Wan et al, 2020",Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing,S84,a5 (n=40),severe,32198776,China,English,40,,Time_onset_admission,,,,,,,,,40,,,95,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,albumin,,,37,33,39,6,37,4.444444444,82,32,3.703703704,334,37,4.444444444
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,albumin,,,32,29,34,5,32,3.703703704,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,ALT,,,28,18,46,28,28,20.74074074,82,29,18.5185185,334,28,20.74074074
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,ALT,,,29,19,44,25,29,18.51851852,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,AST,,,29,21,40,19,29,14.07407407,82,40,24.44444444,334,29,14.07407407
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,AST,,,40,27,60,33,40,24.44444444,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,creatinine,,,56.576,47.736,68.952,21.216,56.576,15.71555556,82,101.66,78.57777778,334,56.576,15.71555556
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,creatinine,,,101.66,63.648,169.728,106.08,101.66,78.57777778,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,CRP,,,3.7,1,7.3,6.3,3.7,4.666666667,82,10.2,7.851851852,334,3.7,4.666666667
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,CRP,,,10.2,6.4,17,10.6,10.2,7.851851852,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,D-dimer,,,,,,,,,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,D-dimer,,,,,,,,,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,hemoglobin,,,124,112,135,23,124,17.03703704,82,125,17.77777778,334,124,17.03703704
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,hemoglobin,,,125,108,132,24,125,17.77777778,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,LDH,,,,,,,,,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,LDH,,,,,,,,,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,leucocytes,,,5.5,4.2,7.4,3.2,5.5,2.37037037,82,9.4,5.111111111,334,5.5,2.37037037
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,leucocytes,,,9.4,6.9,13.8,6.9,9.4,5.111111111,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,lymphocytes,,,1,0.8,1.4,0.6,1,0.444444444,82,0.6,0.37037037,334,1,0.444444444
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,lymphocytes,,,0.6,0.4,0.9,0.5,0.6,0.37037037,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,monocytes,,,,,,,,,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,monocytes,,,,,,,,,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,neutrophiles,,,,,,,,,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,neutrophiles,,,,,,,,,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,potassium,,,4,3.6,4.3,0.7,4,0.518518519,82,4,0.740740741,334,4,0.518518519
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,potassium,,,4,3.6,4.6,1,4,0.740740741,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,Procalcitonin,,,0.06,0.03,0.1,0.07,0.06,0.051851852,82,0.27,0.82962963,334,0.06,0.051851852
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,Procalcitonin,,,0.27,0.1,1.22,1.12,0.27,0.82962963,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,sodium,,,140,138,143,5,140,3.703703704,82,141,5.925925926,334,140,3.703703704
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,sodium,,,141,138,146,8,141,5.925925926,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,thrombocytes,,,216,165,273,108,216,80,82,172,77.03703704,334,216,80
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,thrombocytes,,,172,111,215,104,172,77.03703704,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),non-severe,32211816,China,English,82,,Time_onset_admission,1,28,10,,,27,10,20,82,,,334,,
"Shi et al, 2020","Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China",S69,a12 (n=82),severe,32211816,China,English,82,,Time_onset_admission,1,30,10,,,29,10,21.48148148,82,,,334,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,albumin,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,albumin,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,ALT,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,ALT,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,AST,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,AST,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,creatinine,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,creatinine,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,CRP,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,CRP,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,D-dimer,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,D-dimer,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,hemoglobin,,,135,120,148,28,135,20.74074074,173,128,21.48148148,926,135,20.74074074
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,hemoglobin,,,128,112,141,29,128,21.48148148,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,LDH,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,LDH,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,leucocytes,,,4.9,3.8,6,2.2,4.9,1.62962963,173,3.7,2.37037037,926,4.9,1.62962963
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,leucocytes,,,3.7,3,6.2,3.2,3.7,2.37037037,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,lymphocytes,,,1,0.8,1.4,0.6,1,0.444444444,173,0.8,0.296296296,926,1,0.444444444
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,lymphocytes,,,0.8,0.6,1,0.4,0.8,0.296296296,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,monocytes,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,monocytes,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,neutrophiles,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,neutrophiles,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,potassium,,,3.9,3.6,4.2,0.6,3.9,0.444444444,173,3.8,0.444444444,926,3.9,0.444444444
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,potassium,,,3.8,3.5,4.1,0.6,3.8,0.444444444,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,Procalcitonin,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,Procalcitonin,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,sodium,,,138.4,136.6,140.4,3.8,138.4,2.814814815,173,138,2.962962963,926,138.4,2.814814815
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,sodium,,,138,136,140,4,138,2.962962963,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,thrombocytes,,,172,139,212,73,172,54.07407407,173,137.5,59.62962963,926,172,54.07407407
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,thrombocytes,,,137.5,99,179.5,80.5,137.5,59.62962963,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),non-severe,32109013,English,China,173,,Time_onset_admission,,,,,,,,,173,,,926,,
"Guan et al, 2020",Clinical Characteristics of Coronavirus Disease 2019 in China,S30,a1 (n=173),severe,32109013,English,China,173,,Time_onset_admission,,,,,,,,,173,,,926,,